{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:16:45Z","timestamp":1790083005509,"version":"4.0.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ymthe.2024.08.026","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T03:12:21Z","timestamp":1725073941000},"page":"3695-3711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Rational design of self-amplifying virus-like vesicles with Ebola virus glycoprotein as vaccines"],"prefix":"10.1016","volume":"32","author":[{"given":"Hong-Qing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Lin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Xuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8895-3679","authenticated-orcid":false,"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.08.026_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev-med-052915-015604","article-title":"Ebola: Anatomy of an Epidemic","volume":"68","author":"Lo","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ymthe.2024.08.026_bib2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1099\/jgv.0.001252","article-title":"ICTV Virus Taxonomy Profile: Filoviridae","volume":"100","author":"Kuhn","year":"2019","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(18)33132-5","article-title":"Ebola virus disease","volume":"393","author":"Malvy","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2024.08.026_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","article-title":"Ebola virus disease","volume":"6","author":"Jacob","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2024.08.026_bib6","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3390\/pathogens10101330","article-title":"Structural and Functional Aspects of Ebola Virus Proteins","volume":"10","author":"Jain","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.ymthe.2024.08.026_bib7","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/S1473-3099(23)00376-6","article-title":"Prevention and post-exposure management of occupational exposure to Ebola virus","volume":"24","author":"Moso","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.08.026_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/vaccines11020268","article-title":"Ebola Virus Disease Vaccines: Development, Current Perspectives\u00a0& Challenges","volume":"11","author":"Malik","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2024.08.026_bib9","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJMra1901594","article-title":"Ebola","volume":"382","author":"Feldmann","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.08.026_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.721328","article-title":"Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection","volume":"12","author":"Tshiani Mbaya","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib11","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1128\/JVI.01184-15","article-title":"Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection","volume":"89","author":"Reynolds","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00504-19","article-title":"Infectious Chikungunya Virus (CHIKV) with a Complete Capsid Deletion: a New Approach for a CHIKV Vaccine","volume":"93","author":"Zhang","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01480-21","article-title":"High-Titer Self-Propagating Capsidless Chikungunya Virus Generated in Vero Cells as a Strategy for Alphavirus Vaccine Development","volume":"96","author":"Zhang","year":"2022","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102819","article-title":"A novel rabies vaccine based on infectious propagating particles derived from hybrid VEEV-Rabies replicon","volume":"56","author":"Zhang","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2024.08.026_bib15","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1128\/JVI.03361-12","article-title":"Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus","volume":"87","author":"Herbert","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ymthe.2022.10.011","article-title":"Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection","volume":"31","author":"Krahling","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.08.026_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0092-8674(94)90258-5","article-title":"Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA","volume":"79","author":"Rolls","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.08.026_bib18","doi-asserted-by":"crossref","first-page":"16866","DOI":"10.1073\/pnas.1414991111","article-title":"In\u00a0vitro evolution of high-titer, virus-like vesicles containing a single structural protein","volume":"111","author":"Rose","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.08.026_bib19","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1073\/pnas.0800280105","article-title":"Hybrid alphavirus-rhabdovirus propagating replicon particles are versatile and potent vaccine vectors","volume":"105","author":"Rose","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.08.026_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1128\/JVI.05191-11","article-title":"A novel self-replicating chimeric lentivirus-like particle","volume":"86","author":"Jurgens","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib21","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.3389\/fmicb.2017.02662","article-title":"Alphavirus Replicon DNA Vectors Expressing Ebola GP and VP40 Antigens Induce Humoral and Cellular Immune Responses in Mice","volume":"8","author":"Ren","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0264-410X(00)00113-4","article-title":"Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus","volume":"19","author":"Pushko","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2024.08.026_bib23","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1128\/JVI.76.10.4855-4865.2002","article-title":"Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP","volume":"76","author":"Noda","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/22221751.2022.2030198","article-title":"A new screening system for entry inhibitors based on cell-to-cell transmitted syncytia formation mediated by self-propagating hybrid VEEV-SARS-CoV-2 replicon","volume":"11","author":"Li","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ymthe.2024.08.026_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/jmbi.2000.3822","article-title":"Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus","volume":"300","author":"Ruigrok","year":"2000","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib26","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1128\/JVI.77.3.1812-1819.2003","article-title":"Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4","volume":"77","author":"Licata","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009616","article-title":"P300-mediated NEDD4 acetylation drives ebolavirus VP40 egress by enhancing NEDD4 ligase activity","volume":"17","author":"Zhang","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2024.08.026_bib28","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.aad6117","article-title":"Structural and molecular basis for Ebola virus neutralization by protective human antibodies","volume":"351","author":"Misasi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.08.026_bib29","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1128\/JVI.76.24.12463-12472.2002","article-title":"Covalent modifications of the ebola virus glycoprotein","volume":"76","author":"Jeffers","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/glycob\/cwy053","article-title":"Addicted to sugar: roles of glycans in the order Mononegavirales","volume":"29","author":"Ortega","year":"2019","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymthe.2024.08.026_bib31","doi-asserted-by":"crossref","first-page":"9596","DOI":"10.1128\/JVI.00784-09","article-title":"Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins","volume":"83","author":"Reynard","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01967-19","article-title":"Mucin-Like Domain of Ebola Virus Glycoprotein Enhances Selective Oncolytic Actions against Brain Tumors","volume":"94","author":"Zhang","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.virs.2024.03.008","article-title":"A lethal mice model of recombinant vesicular stomatitis viruses for EBOV-targeting prophylactic vaccines evaluation","volume":"39","author":"Zhang","year":"2024","journal-title":"Virol. Sin."},{"key":"10.1016\/j.ymthe.2024.08.026_bib34","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1128\/jvi.69.8.4792-4796.1995","article-title":"Antiviral defense in mice lacking both alpha\/beta and gamma interferon receptors","volume":"69","author":"van den Broek","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib35","doi-asserted-by":"crossref","first-page":"10394","DOI":"10.1128\/JVI.77.19.10394-10403.2003","article-title":"An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector","volume":"77","author":"Perri","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib36","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.08.026_bib37","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.4049\/jimmunol.1601877","article-title":"Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design","volume":"198","author":"Pepini","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1471-4906(03)00121-2","article-title":"Immune responsiveness, tolerance and dsRNA: implications for traditional paradigms","volume":"24","author":"von Herrath","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib39","article-title":"Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant","volume":"2010","author":"Jin","year":"2010","journal-title":"J.\u00a0Biomed. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.719077","article-title":"Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and alphaOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity","volume":"12","author":"Scaglione","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib41","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/v11050410","article-title":"Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion","volume":"11","author":"Pleet","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2024.08.026_bib42","doi-asserted-by":"crossref","first-page":"S365","DOI":"10.1093\/infdis\/jiy472","article-title":"Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles","volume":"218","author":"Pleet","year":"2018","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2024.08.026_bib43","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1128\/JVI.78.14.7344-7351.2004","article-title":"Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles","volume":"78","author":"Licata","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib44","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ymthe.2019.01.008","article-title":"Exosome-Mediated miR-29 Transfer Reduces Muscle Atrophy and Kidney Fibrosis in Mice","volume":"27","author":"Wang","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.08.026_bib45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba3967","article-title":"Targeted exosome coating gene-chem nanocomplex as \"nanoscavenger\" for clearing alpha-synuclein and immune activation of Parkinson's disease","volume":"6","author":"Liu","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymthe.2024.08.026_bib47","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1080\/21645515.2019.1649532","article-title":"Recombinant vesicular stomatitis virus vector vaccines for whom blueprint priority pathogens","volume":"15","author":"Fathi","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ymthe.2024.08.026_bib48","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1128\/JVI.75.8.3706-3718.2001","article-title":"Role of alpha\/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region","volume":"75","author":"White","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib49","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1128\/JVI.01283-07","article-title":"A five-amino-acid deletion of the eastern equine encephalitis virus capsid protein attenuates replication in mammalian systems but not in mosquito cells","volume":"82","author":"Aguilar","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib50","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1128\/JVI.02075-06","article-title":"Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression","volume":"81","author":"Aguilar","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.virol.2013.07.023","article-title":"Non-encapsidation activities of the capsid proteins of positive-strand RNA viruses","volume":"446","author":"Ni","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2024.08.026_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01970-16","article-title":"Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design","volume":"8","author":"Taylor","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.ymthe.2024.08.026_bib53","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1089\/jir.2019.0123","article-title":"Mechanisms of Innate Immune Activation by a Hybrid Alphavirus-Rhabdovirus Vaccine Platform","volume":"40","author":"Marchese","year":"2020","journal-title":"J.\u00a0Interferon Cytokine Res."},{"key":"10.1016\/j.ymthe.2024.08.026_bib54","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1021\/mp4001316","article-title":"Modeling pre-existing immunity to adenovirus in rodents: immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine","volume":"10","author":"Choi","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2024.08.026_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02469-16","article-title":"Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys","volume":"91","author":"Lingemann","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib56","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2005.10.042","article-title":"Chimpanzee adenovirus vaccine protects against Zaire Ebola virus","volume":"346","author":"Kobinger","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2024.08.026_bib57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.vaccine.2010.10.024","article-title":"Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response","volume":"29","author":"DiNapoli","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2024.08.026_bib58","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1128\/JVI.02407-10","article-title":"Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge","volume":"85","author":"Geisbert","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib59","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fmicb.2013.00267","article-title":"Animal models for Ebola and Marburg virus infections","volume":"4","author":"Nakayama","year":"2013","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib60","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1016\/j.jmb.2016.05.008","article-title":"Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis","volume":"428","author":"Banadyga","year":"2016","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ymthe.2024.08.026_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29401-x","article-title":"A VSV-based Zika virus vaccine protects mice from lethal challenge","volume":"8","author":"Emanuel","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.08.026_bib62","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/infdis\/jiad238","article-title":"A Chimeric Classical Insect-Specific Flavivirus Provides Complete Protection Against West Nile Virus Lethal Challenge in Mice","volume":"229","author":"Zhang","year":"2024","journal-title":"J.\u00a0Infect. Dis."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624005823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624005823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T21:06:23Z","timestamp":1759611983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624005823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1525001624005823"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.08.026","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design of self-amplifying virus-like vesicles with Ebola virus glycoprotein as vaccines","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}